Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure

Overview

Journal Card Fail Rev

Date 2022 May 6

PMID 35516795

Authors

Juan Carlos Lopez-Azor

Noelia De la Torre

Maria Dolores Garcia-Cosio Carmena

Pedro Caravaca Perez

Catalina Munera

Irene MarcoClement

Rocio Cozar Leon

Jesus Alvarez-Garcia

Marta Pachon

Fernando Arribas Ynsaurriaga

Rafael Salguero Bodes

Juan Francisco Delgado Jimenez

Javier de Juan Baguda

Affiliations

Soon will be listed here.

Abstract

Telemonitoring through multiple variables measured on cardiac devices has the potential to improve the follow-up of patients with heart failure. The HeartLogic algorithm (Boston Scientific), implemented in some implantable cardiac defibrillators and cardiac resynchronisation therapy, allows monitoring of the nocturnal heart rate, respiratory movements, thoracic impedance, physical activity and the intensity of heart tones, with the aim of predicting major clinical events. Although HeartLogic has demonstrated high sensitivity for the detection of heart failure decompensations, its effects on hospitalisation and mortality in randomised clinical trials has not yet been corroborated. This review details how the HeartLogic algorithm works, compiles available evidence from clinical studies, and discusses its application in daily clinical practice.

Citing Articles

Prediction of heart failure events based on physiologic sensor data in HINODE defibrillator patients.

Nishii N, Sakata Y, Murohara T, Ando K, Ikeda T, Mitsuhashi T ESC Heart Fail. 2024; 11(5):3322-3331.

PMID: 38956896 PMC: 11424318. DOI: 10.1002/ehf2.14890.

Clinical Predictive Modeling of Heart Failure: Domain Description, Models' Characteristics and Literature Review.

Odrobina I Diagnostics (Basel). 2024; 14(4).

PMID: 38396482 PMC: 10888082. DOI: 10.3390/diagnostics14040443.

The patient perspective on remote monitoring of implantable cardiac devices.

Hillmann H, Hansen C, Przibille O, Duncker D Front Cardiovasc Med. 2023; 10:1123848.

PMID: 36937908 PMC: 10017432. DOI: 10.3389/fcvm.2023.1123848.

Personalized Therapy and Clinical Outcome for Heart Failure.

Acena A, de Juan Baguda J, Rincon L J Clin Med. 2022; 11(16).

PMID: 36013089 PMC: 9410394. DOI: 10.3390/jcm11164851.

References

Whellan D, Ousdigian K, Al-Khatib S, Pu W, Sarkar S, Porter C . Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients.... J Am Coll Cardiol. 2010; 55(17):1803-10. DOI: 10.1016/j.jacc.2009.11.089. View

Auricchio A, Gold M, Brugada J, Nolker G, Arunasalam S, Leclercq C . Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: Results of the Clinical Evaluation of the Physiological.... Eur J Heart Fail. 2014; 16(6):663-70. DOI: 10.1002/ejhf.79. View

Givertz M, Stevenson L, Costanzo M, Bourge R, Bauman J, Ginn G . Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2017; 70(15):1875-1886. DOI: 10.1016/j.jacc.2017.08.010. View

Guedon-Moreau L, Lacroix D, Sadoul N, Clementy J, Kouakam C, Hermida J . A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J. 2012; 34(8):605-14. PMC: 3578267. DOI: 10.1093/eurheartj/ehs425. View

Gardner R, Thakur P, Hammill E, Nair D, Eldadah Z, Stancak B . Multiparameter diagnostic sensor measurements during clinically stable periods and worsening heart failure in ambulatory patients. ESC Heart Fail. 2021; 8(2):1571-1581. PMC: 8006698. DOI: 10.1002/ehf2.13261. View

de Juan Baguda J, Gavira Gomez J, Pachon Iglesias M, Cozar Leon R, Escolar Perez V, Gonzalez Fernandez O . Remote heart failure management using the HeartLogic algorithm. RE-HEART registry. Rev Esp Cardiol (Engl Ed). 2021; 75(9):709-716. DOI: 10.1016/j.rec.2021.09.015. View

Treskes R, Beles M, Caputo M, Cordon A, Biundo E, Maes E . Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients. ESC Heart Fail. 2021; 8(2):1541-1551. PMC: 8006675. DOI: 10.1002/ehf2.13252. View

Varma N, Epstein A, Irimpen A, Schweikert R, Love C . Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010; 122(4):325-32. DOI: 10.1161/CIRCULATIONAHA.110.937409. View

Van Veldhuisen D, Braunschweig F, Conraads V, Ford I, Cowie M, Jondeau G . Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011; 124(16):1719-26. DOI: 10.1161/CIRCULATIONAHA.111.043042. View

10.

Farre N, Vela E, Cleries M, Bustins M, Cainzos-Achirica M, Enjuanes C . Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients. Eur J Heart Fail. 2016; 18(9):1132-40. DOI: 10.1002/ejhf.549. View

11.

Gheorghiade M, De Luca L, Fonarow G, Filippatos G, Metra M, Francis G . Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol. 2005; 96(6A):11G-17G. DOI: 10.1016/j.amjcard.2005.07.016. View

12.

Calo L, Bianchi V, Ferraioli D, Santini L, Dello Russo A, Carriere C . Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice. Circ Heart Fail. 2021; 14(10):e008134. PMC: 8522625. DOI: 10.1161/CIRCHEARTFAILURE.120.008134. View

13.

Gardner R, Singh J, Stancak B, Nair D, Cao M, Schulze C . HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study. Circ Heart Fail. 2018; 11(7):e004669. DOI: 10.1161/CIRCHEARTFAILURE.117.004669. View

14.

Lindenfeld J, Zile M, Desai A, Bhatt K, Ducharme A, Horstmanshof D . Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet. 2021; 398(10304):991-1001. DOI: 10.1016/S0140-6736(21)01754-2. View

15.

Arya A, Block M, Kautzner J, Lewalter T, Mortel H, Sack S . Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study. Eur J Heart Fail. 2008; 10(11):1143-8. DOI: 10.1016/j.ejheart.2008.08.004. View

16.

Santini L, DOnofrio A, Dello Russo A, Calo L, Pecora D, Favale S . Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring. Clin Cardiol. 2020; 43(7):691-697. PMC: 7368302. DOI: 10.1002/clc.23366. View

17.

Bourge R, Abraham W, Adamson P, Aaron M, Aranda Jr J, Magalski A . Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008; 51(11):1073-9. DOI: 10.1016/j.jacc.2007.10.061. View

18.

Kleiner Shochat M, Shotan A, Blondheim D, Kazatsker M, Dahan I, Asif A . Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial). J Card Fail. 2016; 22(9):713-22. DOI: 10.1016/j.cardfail.2016.03.015. View

19.

Adamson P . Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. Curr Heart Fail Rep. 2009; 6(4):287-92. DOI: 10.1007/s11897-009-0039-z. View

20.

Crespo-Leiro M, Anker S, Maggioni A, Coats A, Filippatos G, Ruschitzka F . European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016; 18(6):613-25. DOI: 10.1002/ejhf.566. View